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Abstract
Background: Free fatty acids have been reported to impair insulin action; Dietary fat composition has been
implicated in the development of insulin resistance as well as fasting glycaemia and type 2 diabetes mellitus. This
work was designed to determine the benefits of consuming vegetable oils on the management of diabetes in
diabetic mice.
Methods: Forty eight (48) maledb/db diabetic mice were randomly divided into eight groups of six. The first four
groups were fed on chow (control), 10 % Red palm oil feed, 10 % groundnut oil feed, and 10 % coconut oil feed.
The second four groups were fed similar to the first four groups but in addition were administered glibenclamide
(2 mg/kg -wt i.p) daily at 8. AM.
Results: Plasma glucose in the diabetic mice was significantly reduced after consuming diets fortified with 10 %
palm oil, groundnut oil and coconut oil and also in mice additionally treated with glibenclamide. In mice that were
not treated glibenclamide, treatment with groundnut oil reduced total cholesterol and LDL-cholesterol and raised
plasma HDL. Plasma triglycerides were unchanged. Palm oil and coconut oil had no effect on any of the plasma
lipids. In mice that were treated glibenclamide, the control and palm oil treatment significantly reduced total
cholesterol (p < 0.05). The control, groundnut oil, palm oil and coconut oil significantly (p < 0.05) reduced plasma
LDL-cholesterol. HDL-cholesterol was raised in groundnut oil, and coconut oil. Plasma triglycerides were raised in
only on groundnut oil.
Conclusion: Ten percent fortified vegetable oil feeds (red palm oil, groundnut oil and coconut oil) significantly
improved lipid profile and significantly reduced blood glucose in diabetic mice. Groundnut oil raised HDL and
lowered LDL even in mice given glibenclamide but it did not lower total cholesterol in mice given glibenclamide
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Background
Increased plasma free fatty acids reduced insulin-
stimulated glucose-uptake. The mechanism responsible
for this inhibition, however, remains unclear. There is
sufficient evidence suggesting that the defects in glucose
uptake and storage in the presence of free fatty acids
may be related to abnormal fat metabolism [1, 2]. Most
patients with type 2 diabetes are obese and have elevated
plasma free fatty acids concentrations [3], and these have
been shown to inhibit insulin-stimulated glucose uptake
[4, 5]. The Randle glucose-fatty acid cycle has been used
to explain insulin resistance in skeletal muscle of
patients with type 2 diabetes or obesity. An alternative
hypothesis proposes that muscle insulin resistance re-
sults from decreased mitochondrial oxidation of fatty
acids [6–9]. The unoxidized fatty acids are re-routed to-
ward the synthesis of diacylglycerol and ceramide, which
in turn stimulate stress-induced protein kinases that
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inhibit insulin signalling [8, 9]. This hypothesis is sup-
ported by measurement of the concentrations of lipids
in mitochondrial oxidative capacity, and the phosphoryl-
ation state of several components of the insulin-
signalling pathway in hearts perfused with palmitate in
pathological samples from type 2 diabetic patients [10].
Increasing evidence implicates dietary fat compos-
ition in the development of insulin resistance, includ-
ing impaired fasting glycaemia and Type 2 diabetes
mellitus [11, 12]. Several cross-sectional studies have
shown an association between dietary saturated fat
content and hyperinsulinaemia [13] impaired glucose
tolerance [14, 15] and overt diabetes [16]. Groundnut
oil contains 46 and 32% of mono unsaturated fatty
acids (MUFA) and polyunsaturated fatty acids (PUFA),
respectively Palm oil contains approximately 50 % of
saturated and 50 % unsaturated fatty acids [17], whilst
coconut oil is, a saturated fat which contains predom-
inantly medium-chain saturated fatty acids with high
antioxidant properties [18–20].
Several management strategies of diabetes such as
dietary modification, exercise, oral hypoglycaemic
agents, and insulin have been in used for decades. How-
ever, these regimen have not adequately proven to be ef-
fective in curbing the complications associated with
diabetes mellitus [21]. Vegetable oils have also been
found to be useful in the management of diabetes [22].
These oils contains different fractions of fat and other
component such as tocotrienols, tocopherols, oryzanol,
phytosterols which have varying effect on insulin resist-
ance and metabolic control [23]. Many vegetable oils in-
cluding groundnut oil, red palm oil, coconut oil and
palm kennel oil are widely used in many developing
countries as part of their dietary preparations. A
favourable glucose response was also induced by fish oil
feeding and this was mediated through body weight loss
[24]. Noninsulin diabetic model mice fed on palm oil
had improved glycaemic control despite their marked
obesity [25]. However, public perception that intake of
these edible oils contributes to dyslipidaemia and
increase cardiovascular risk has reduced their consump-
tion. It is against this background that this study was
aimed at determining the metabolic effect of some vege-
table oil consumption in the management of diabetes in
diabetic mice.
Methods
All procedures and techniques used in this study were in
accordance with the National Institute of Health Guide
lines for the care of Laboratory Animals (NIH). Department
of Health Service Publication No 83-23, revised 1985). The
protocol for the study was approved by the Health Service
Ethics committee, School of Medical Sciences, Kwame
Nkrumah University of Science and Technology Kumasi-
Ghana.
Forty eight (48) male diabetic mice (BKS.Cg-m
+/+Leprdb/BomTac) strain each weighing between 25
and 40 g and a mean weight of 35 g and approximately
8 weeks old were obtained from the Department of
Animal Experimentation, Nuguchi Memorial Institute
for Medical Research, University of Ghana. The mice
were transported in specialized cages and brought to the
Animal house of the pharmacology Department, Kwame
Nkrumah University of Science and Technology
(KNUST)-Ghana where the study was carried out. The
mice were housed in groups of two at 25–30 °C with
12 h daylight. The mice were fed ad libitum with normal
rodent chow (composed of 21 % protein, 5 % fat and
34 % carbohydrate, made from fish meal, maize, rice and
wheat bran) was bought from the Nuguchi Memorial
Institute for Medical Research laboratories (Department
of Animal Experimentation) Accra – Ghana.
Diet preparation
The test diets were prepared by mixing 10 g vegetable
oils with 90 g normal commercial rodent chow to obtain
a 10 % by weight of the vegetable oils. Three different
10 % fat diets were prepared by adding red palm oil (ex-
tracted from the pulp of African oil palm (Elaeisguineen-
sis), groundnut oil (extracted from the nuts of
Arachishypogaea) and coconut oil (extracted from the
kennel of Cocosnucifera) and pure chow as control diet
and kept in a refrigerator until use. The supplementation
in vegetable oils is in addition to the 5 % fats that are in
the 90 % of the chow. The vegetable oils were bought
from the Ghana Food Distribution Corporation. The red
palm oil is composed of 51 % saturated fatty acid, 39 %
monounsaturated fatty acids and 10 % polyunsaturated
fatty acids. The groundnut oil is composed of 18 % satu-
rated fatty acid, 48 % monounsaturated fatty acids and
34 % polyunsaturated fatty acids, whilst the coconut oil
is composed of 92 % saturated fatty acid, 6 % monoun-
saturated fatty acids and 2 % polyunsaturated fatty acids.
Experimental design
After one week of acclimatization, during which period
mice were fed on normal chow ad libi tum, overnight
fasting glucose levels were determined. Only mice whose
fasting glucose was ≥ 11.0 mmol/L were selected for the
experiment.
The selected animals were randomly divided into eight
groups of six animals each:
Groups I–IV were on diet treatment only and group
V–VIII, were additionally treated glibenclamide
(2 mg/kg body-wt, i.p) daily at 8.00 AM, for the
4 week period as follows)
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Group I: chow (control)
Group II: groundnut oil diet
Group III: palm oil diet
Group IV: coconut oil diet
Group V: Chow + glibenclamide (2 mg/kg b-wt)
Group VI: groundnut oil diet + glibenclamide (2 mg/kg
b-wt)
Group VII: palm oil diet + glibenclamide (2 mg/kg b-wt)
Group VIII: coconut oil diet + glibenclamides
(2 mg/kg b-wt)
Biochemical assay
After 28 days of treatment, the 12 h-fasted animals
were killed by cervical decapitation between 8 AM.
and 9 AM. About 2.0 ml of blood sample was taken
from each mouse, of which 1.5 ml was dispensed into
a plain tube to clot whiles 0.5 ml of the blood was
put into separate EDTA tubes. The tubes were then
placed in a centrifuge and spun at 3000 x g for
10 min to obtain the plasma and sera. Plasma glucose
was measured immediately and the serum for the
measurement of other biochemical variables was
stored at−80 °C until analysis.
Biochemical assays including glucose, Total choles-
terol, LDL-cholesterol, HDL-cholesterol, triglycerides,
were analysed using the automated analyser, Mindray
Chemistry Analser (BS 120) (China) with reagent kits
manufactured by the (ELITech Clinical System SAS 2.1
61500 SEES- FRANCE 2014-2010) compatible with the
auto analyser, and according to the reagent kit manufac-
turer’s protocol.
Statistical analysis
The data analysis was done using Graph Pad Prism ver-
sion 5.00 for windows (GraphPad Software, San Diego
California, USA). Baseline characteristics were expressed
as mean ± standard error of means (SEM). One-way ana-
lysis of variance (ANOVA) with Dunnett’s test was used
for multiple comparisons between metabolic groups. P
value <0.05 was considered significant.
Results and discussion
The management of type 2 diabetes mellitus includes
the use of diet, exercise, oral hypoglycemic agents, and
insulin. However, these remedies do not effectively pre-
vent the complications of diabetes mellitus [21]. Extracts
of many local medicinal plants have been successfully
used in the management of diabetes [26]. Some dietary
fats have also been reported to be effective in lowering
blood glucose [16]. However, dietary fat may also have a
negative effect on the lipid profile [27] which may negate
the gains of glucose lowering.
Dietary fats differ in chain length and degree of unsat-
uration and this affects plasma lipoprotein constitution
[28]. Serum cholesterol level increases when dietary
carbohydrates are replaced by saturated fatty acids and
decreases when carbohydrates are replaced by polyunsat-
urated fatty acids containing omega 3 [27]. Studies have
suggested that the cholesterol-decreasing effect of poly-
unsaturated fatty acids affects both LDL and HDL chol-
esterol [28, 29]. However, the mechanism by which these
fats affect serum lipoproteins concentration is unclear.
Plasma total cholesterol, and LDL (Table 1) were signifi-
cantly (p <0.05) reduced and HDL-cholesterol was in-
creased in diabetic mice fed on the groundnut oil diet,
whilst the palm oil and coconut oils diets did not have
any significant effects. None of the diets significantly af-
fected the plasma triglycerides level. This means that the
consumption of these vegetable oils does not pose car-
diovascular risk. This is supported by the low cardiovas-
cular risk index (HDL-cholesterol/Total cholesterol)
Tables 1 and 2.
Humans and animal studies have shown that, satu-
rated fat intake increases both LDL and high-density
lipoprotein (HDL) cholesterol levels [30, 31]. The
increased LDL is due to the inhibiting of LDL recep-
tor activity and thus enhancing apolipoprotein (apo)
B-containing lipoprotein production [32]. In contrast,
intake of polyunsaturated fatty acids had a modest
but significant LDL cholesterol-lowering effect [33].
The lowering of LDL cholesterol in mice fed with
Table 1 The effect of vegetable oil consumption on plasma lipid profile in diabetic Mice
Vegetable oil without Glibenclimide treatment
Parameters Control (C) Palm (PO) Groundnut (GO) Coconut (CO) p-value
TC (mmol/l) 3.72 ± 0.10 3.51 ± 0 .04 3.18 ± 0 .02a 4.06 ± 0 .18b 0.0010
LDL (mmol/l) 2.57 ± 0 .10 2.37 ± 0 .06 1.67 ± 0.04ba 2.90 ± 0 .20 0.0187
HDL (mmol/l) 0.45 ± 0 .04 0.45 ± 0.04 0.72 ± 0 .06ba 0.42 ± 0 .04 0.0252
TG (mmol/l) 1.52 ± 0 .05 1.50 ± 0 .04 1.70 ± 0 .05 1.60 ± 0.11 0.8973
HDL/TC ratio 0.12 ± 0 .001 0.13 ± 0 .001 0.23 ± 0 .001ba 0.10 ± 0.001 0.0137
Mean effect of vegetable oils on the lipid profile of diabetic mice. Mean value are expressed as mean ± SEM. N = 6 in each group. TC total cholesterol, LDL low
density lipoprotein, HDL high density lipoprotein, TG triglycerides. aindicate significant difference compared to controls, p < 0.05, bindicate significant difference
compared to other vegetable oils. Total cholesterol, LDL, and LDL were significantly reduced in mice fed on groundnut oil diet only (p < 0.05), while HDL was
significantly increased
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groundnut oil diet is consistent with other findings,
particularly considering the fact that groundnut oil
predominantly consists of polyunsaturated fatty acids
[17]. In this study groundnut oil significantly (p
<0.05) raised plasma HDL contrary to findings by
Mattson and Grundy which suggest that polyunsatur-
ated fatty acids lower HDL [34]. Similar results to
our finding have been reported: streptozotocin-
induced diabetes in rats lowered HDL-cholesterol
whilst 8 % groundnut oil raised plasma HDL in
streptozotocin-induced diabetic rats [35]. This may be
because diabetes has a metabolic defect which is
compensated for by an increase in HDL levels.
The exact mechanism by which groundnut oil raised
HDL levels in the diabetic rats is not understood.
When the mice in addition to the oil feed diet were
administered with (2 mg/kg. wt. glibenclamide i.p)
daily for the 4 week period, plasma Total cholesterol
was significantly (p <0.05) reduced in the control and
mice fed on palm oil diet. Plasma LDL levels in dia-
betic mice were significantly (p <0.05) reduced in all
the oil diets and the control plus glibenclamide treat-
ment. HDL was significantly (p <0.05) increased only
in groundnut oil and coconut oil formulated diets.
Triglycerides were only significantly (p <0.05)
increased in the groundnut oil diet (Table 2). It is un-
clear how glibenclamide treatment increases triglycer-
ide lipid subfraction while the others are reduced. To
consider the effect of the oils on treatment with glib-
enclamide, the lipid levels were compared to the con-
trol plus glibenclamide treatment. Total cholesterol
was significantly increased by groundnut oil and
coconut oil. LDL was significantly raised in the coco-
nut oil. HDL was increased only in the groundnut oil
and coconut oils, while triglycerides were also sig-
nificantly increased only in the groundnut oil. Even
though total cholesterol was increased in the
groundnut and coconut oil there was a correspond-
ing significant decrease in cardiovascular risk
(Tables 1 and 2).
Mice fed on groundnut oil, palm oil and coconut oil
diets had significant (p < 0.05) reduction in blood glu-
cose. The reduction in blood glucose in groundnut oil
diet-fed mice may be due to the presence of mono un-
saturated fatty acids (MUFA) [36]. A reduction in
plasma glucose concentration with the consumption of a
MUFA-rich diet has been reported [37]. Indeed it has
also been shown that when the groundnut oil was re-
placed with sesame oil (a much higher percentage poly-
unsaturated fatty acid than groundnuts) the reduction in
glucose was even more significant [38].
Ikemoto et al., attributed reduction of blood glucose
in mice fed on palm oil to palm oil-induced hypersinsu-
lineamia [25]. The high antioxidant effect of both proc-
essed and unprocessed palm oil which could also lead
to reduced blood glucose is due to the carotenoids,
phosphatides, sterols, tocopherols and trace metals
content, and these have been shown to be effective
against oxidative stress in in vitro and in vivo studies
[39]. The carotenoids, together with vitamin E, ascorbic
acid, enzymes and proteins, are members of the bio-
logical antioxidant network converting highly reactive
radicals and free fatty peroxyl radicals to less active
species [40] thus, protecting against oxidative damage
to cells. β-carotene is the most abundant carotenoids
which can be converted to vitamin A; which is import-
ant in the visual process. In addition, it is an antioxi-
dant that destroys singlet oxygen and free radicals [41].
Oral administration of antioxidants extracts from Aloe
vera gel significantly decreased the levels of blood glu-
cose, glycosylated hemoglobin and increased haemoglo-
bin levels [42]. Several other studies have shown that
antioxidants administration indeed reduces blood glu-
cose, glycosylated haemoglobin and the upregulation of
oxidative stress enzymes in diabetic animals [42, 43].
The administration of coconut oil diet, even though
coconut oil is a saturated fat, significantly reduced
blood glucose. The exact mechanism is not understood.
This could also be mediated through its antioxidant ef-
fect [44]. Indeed Houssay and, Martínez showed that
Table 2 Effect of vegetable oils consumption and Glibenclamide treatments on serum lipid profile of diabetic mice
Vegetable oil + Glibenclamide treatment
Parameters Control (C) Control + Glib Palm +Glib Groundnut +Glib Coconut + Glib p-value
TC (mmol/l) 3.72 ± 0.10 3.08 ± 0 .12a 2.77 ± 0 .12a 3.33 ± 0 .09b 3.30 ± 0 .09b 0.0019
LDL (mmol/l) 2.57 ± 0 .10 1.81 ± 0 .14a 1.60 ± 0 .12a 1.41 ± 0.06a 3.09 ± 0 .13ba 0.0001
HDL(mmol/l) 0 .45 ± 0 .04 0.58 ± 0 .03 0.36 ± 0 .02 0.75 ± 0 .04ba 0.71 ± 0 .06ba 0.0021
TG(mmol/l) 1.52 ± 0 .05 1.50 ± 0.09 1.76 ± 0 .08 2.52 ± 0 .06ba 1.60 ± 0.10 0.0313
HDL/TC ratio 0.12 ± 0 .001 0.19 ± 0.001 0.13 ± 0 .001 0.23 ± 0 .001ba 0.22 ± 0.001ba 0.0105
Mean effect of vegetable oils consumption and Glibenclamide treatments onserum lipid profile of diabetic mice. Values are expressed as mean ± SEM. N = 6 in
each group. TC total cholesterol, LDL low density lipoprotein, HDL high density lipoprotein, TG triglycerides Glib glibenclamide. aindicate significant difference
compared to controls, (p < 0.05). bindicates significant difference between (control + glibenclamide) and other vegetable oil diet plus glibenclamide
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administration of coconut oil completely protected
against diabetes [45].
In a Post Hoc Multiple Comparisons analysis (Fig. 1),
plasma glucose in the glibenclamide treated diabetic
mice was surprisingly significantly higher in the palm oil
diet and groundnut oil diet fed mice than in the non
glibenclimide treated mice on palm oil diet and ground-
nut oil diet (p < 0.05). The values were however signifi-
cantly lower than in the control. On the other hand,
plasma glucose in the glibenclamide treated mice on
coconut oil diet was significantly decreased (p < 0.05)
compared to the coconut oil diet only fed mice (Fig. 1).
Sulfonylurea, such as glibenclamide has been widely
used to treat type 2 diabetic patients over a long
period. (Glibenclamide was chosen in this study be-
cause it is one of the antidiabetic drugs recommended
by the Ministry of Health- Ghana for the manage-
ment of diabetes). The mechanism of action of this
drug has been so controversial. However; all do agree
that the hypoglycaemic effect is mediated through in-
creased insulin secretion [46]. Free fatty acids have
been shown to impair insulin sensitivity [47]. The ef-
fect of fatty acids on sulfonylureas may be varied.
Palm oil and groundnut oil had inhibitory effect on
glibenclamide activity, hence plasma glucose was sig-
nificantly (p < 0.05) higher in mice fed on these oils
plus glibenclamide treatment than mice on the oils
feeds alone (Fig. 1). Zambon et al., showed similar ef-
fect of fish oil (ω3) on glyburide. Fish oil alone sig-
nificantly reduced blood glucose. However when the
Fish oil was administered together with glyburide, the
hypoglycaemic effect was reduced [48]. The mechan-
ism by which these vegetable oils partially impair the
activities of glibenclamide and fish oil impairs glybur-
ide is unclear. It may be that these oils partially im-
pair the activity of the glibenclamide-induced insulin
secretion, as suggested by Boden [47]. However, the
effect of coconut oil on glibenclamide activity was
additive. The hypoglycaemic effect of glibenclamide
plus coconut oil alone was significantly (p < 0.05)
higher than the effect of coconut alone (Fig. 1). Coco-
nut oil may therefore induce insulin secretion that
may argument the insulin secretion induced by glib-
enclamide or at least improves insulin sensitivity, or
the effect may be mediated through some other
mechanism.
Food consumption rate was determined by the
amount of food intake per kilogram body weight of
the mice. Even though there was no significant
change in food consumption per gram weight of mice
compared to the control, there was a consistent
tendency for decreased consumption of the oil formu-
lated diets compared to the control chow (Fig. 2). Re-
cent studies have shown that body weight loss can be
achieved by increase in fat intake, which is mediated
through early satiety or filling, resulting in lower total
calorific intake compared to a carbohydrate diet that
would require high filling and higher calories [49].
This non-significant reduction in food consumption
corresponded with a nonsignificant body weight loss.
(Table 3). Since growth rate is time dependent, it is
possible that the reduction in food consumption and
Fig. 1 The effect of vegetable oil consumption on glibenclamide activity in diabetic Mice. Mean effect of vegetable oils on glucose level on
diabetic mice after oil diet feed. * indicate significant difference compared to controls, (p < 0.05). Mean value were significantly different from the
control group. # indicate significant difference compared to other vegetable oils (p < 0.05). Mean value were significantly different from its
comparative vegetable oil only (*P < 0.05, #P < 0.05, Post Hoc Multiple Comparisons)
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body weight loss would have become significant if the
period of study had been extended to six or more
weeks as has been reported by Danqua.et al. [50].
Conclusion
There was significant improvement of lipid profile in
diabetic mice fed on 10 % vegetable oil fortified meal.
Total cholesterol was significantly reduced in mice
fed on groundnut oil only and palm oil diets plus
glibenclamide treatment. Palm oil and groundnut oil
diets and coconut oil plus glibenclamide treatment
significantly reduced plasma LDL levels in mice fed
on the diets. HDL cholesterol was significantly in-
creased in mice on groundnut oil diets only. Plasma
glucose in the diabetic mice was significantly reduced
after consuming diets fortified with 10 % palm oil,
groundnut oil and coconut oil. 10 % Groundnut oil,
palm oil and coconut oil feeding had antidiabetic
properties with no cardiovascular risk in diabetic
mice.
Fig. 2 The effect of vegetable oil consumption on food intake in diabetic Mice. Mean effect of vegetable oils on feed consumption per body
weight for diabetic mice. *Mean value were nonsignificantly different from the control group (*P < 0.05,Post Hoc Multiple Comparisons)
Table 3 Effect of vegetable oil diet on weight of diabetic mice
Groups/treatments Mean weight (g) p-value compared to control(C)
Control (C) (chow) 0.39 ± 0.01 -
Vegetable oil without Glibenclamide
Palm (PO) diet 0.27 ± 0.00 0.5981
Groundnut (GO) diet 0.27 ± 0.00 0.5981
Coconut (CO) diet 0.28 ± 0.00 0.7139
Vegetable oil + Glibenclamide (Glib)
Control (chow) + Glib 0.36 ± 0.00 0.9014
Palm oil diet + Glib 0.27 ± 0.00 0.5981
Groundnut oil diet + Glib (GO + G) 0.34 ± 0.00 0.7881
Coconut oil diet + Glib (CO + G) 0.27 ± 0.00 0.5981
Effect of vegetable oil diet on weight gain of diabetic mice. Values are presented as Mean + SEM. N = 6 in each group. There was no significant weight gain in the
diabetic mice on all the vegetable oil formulated diets compared to the control mice on chow only (P < 0.05, Post Hoc Multiple Comparisons)
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